Madrigal Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resme…
Biotechnology
US, West Conshohocken [HQ]
MDGL/Financials
Segments · Problems · Premarket · Compliance

Segment Analysis

Segment Analysis
Revenue · By Business Segment
Not available for MDGL
Revenue · By Area
Not available for MDGL
End of MDGL's Analysis
CIK: 1157601 CUSIP: 558868105 ISIN: US5588681057 LEI: - UEI: -
Secondary Listings
MDGL has no secondary listings inside our databases.